Abiopharma

News list

Ball Jack 🟡 adjusted position in 0 shares (1 derivative) of Cytek Biosciences, Inc. (CTKB) Transaction Date: Jun 10, 2026 | Filing ID: 000001

Full text

News bot June 12, 2026, 11:34 p.m.
🔍 Ball Jack (Executive)

Company: Cytek Biosciences, Inc. (CTKB)

Report Date: 2026-06-10
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 43,973
- Total shares sold: 43,973
Detailed Transactions and Holdings:
- Acquired 43,973 shares of Common Stock (Direct)
  Date: 2026-06-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 86,678.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 43,973 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-10 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
- F2: 100% of the shares subject to the RSU Award vested on June 10, 2026.